A B S T R A C T The influence of the serum binding protein (DBP) for vitamin D and its metabolites on the concentration of its main ligands, 25-hydroxyvitamin D3 (25-OHD3) and 1,25-dihydroxyvitamin D3 (1,25-[OHh2D3) was studied. The concentration of both 1,25-(OH)2D3 and DBP in normal female subjects (45±14 ng/liter and 333±58 mg/liter, mean+SD, respectively; n = 58) increased during the intake of estro-progestogens (69±27 ng/liter and 488±90 mg/liter, respectively; n = 29), whereas the 25-OHD3 concentration remained unchanged. A positive correlation was found between the concentrations of 1,25-(OH)2D3 and DBP in these women.
INTRODUCTION
The serum concentrations of thyroid hormones and cortisol depend on the concentration oftheir respective transport proteins, and only the concentration of free hormone is considered to be physiologically important (1, 2) . The vitamin D metabolites are also transported in the blood bound to a specific transport protein, called vitamin D-binding protein (DBP).' It was previously shown that there is no correlation between the serum concentration of 25-hydroxyvitamin D3 and DBP, indicating that the level of free 25-OHD3 is not feedback regulated (3) . The serum concentration of la,25-dihydroxyvitamin D3 (1,25- [OHh2D3) increases during human pregnancy (4) (5) (6) (7) (8) , and this has been interpreted as a physiological adaptation to increase the intestinal calcium absorption in compensation for or even anticipation of the transfer of calcium to the fetus (8) . The serum concentration of DBP, however, also increases during pregnancy or during the intake of estro-progestogens (3, 9) , and the relative increase in both concentrations has not been compared. The concentration of DBP in maternal and cord sera has also an important influence on the concentration of 25-OHD3 in both circulations (3) , and ' Abbreviations used in this paper: DBP, serum binding protein for vitamin D and its hydroxylated metabolites; we now report a similar influence on the serum concentration of 1,25-(OH)2D3.
METHODS
Subjects. After informed consent, blood was taken from 58 healthy female blood donors without any medication (mean age 26 yr) and from 29 women (mean age 28 yr) taking estro-progestogens as oral contraceptive for at least one menstrual cycle. 50 women were also studied during pregnancy, and blood samples were obtained from 62 mothers and their infants at the time of delivery at the St. Rafael Hospital of Leuven, Belgium. Of these children, 40 were born at term (40±1 wk of gestation, mean±SD) with a birth weight of 3,469±308 g. 22 children were born prematurely (35±1 wk of gestation) with a mean birth weight of2,299 g (SD = 433 g). No vitamin D supplementation was given to the mothers, and the blood samples were randomly collected throughout the year. The average vitamin D intake in a pregnant Belgian population is -7 gg/d.
Samples. Peripheral venous blood was taken from the adult females, kept at 4°C, and centrifuged; the serum was then stored at -20°C. Mixed arterial and venous cord blood was treated similarly. In addition, separate blood from the cord artery and cord veins were collected in five cases. Paired samples from mothers and neonates were always run in the same assay to minimize interassay variation.
Methods. Serum 25-OHD3 was measured by competitive protein-binding assay after extraction and Sephadex LH-20 chromatography as previously described (10) . The betweenassay variation was 10% for a sample containing 21 ,ug/liter (n = 50). Serum 1,25-(OH)2D3 was measured by radioimmunoassay (11) . For this assay, 2.5-5 ml of serum was extracted and purified sequentially on Sephadex LH-20 and high pressure liquid chromatography on a silicic acid column. The assay value was corrected by monitoring the overall recovery in each sample (mean 48+3%, n = 50) and the between-assay variation coefficient was 13% for a serum sample containing 42 ng/liter (n = 24). The competitive protein-binding assay for 25-OHD3 did not discriminate between 25-OHD3 and 25-OHD2, but our radioimmunoassay of 1,25-(OH)2D3 had only a low cross-reaction with 1,25-(OH)2D2. Since, no vitamin D2 supplementation was used in our population, however, the values were expressed as the concentration of vitamin D3 metabolites. Serum DBP was measured by single radial immunodiffusion with a betweenassay coefficient of variation of 2.5% (12) could not be directly measured accurately because of their very low concentration and because of the problem of purity and adsorption of these steroids (14, 15 
RESULTS
Serum DBP. The serum concentration of DBP increased during pregnancy and reached a maximum between 32 and 35 wk of gestation, followed by a small decrease at term. The cord serum concentration of DBP was lower than in nonpregnant females, without significant difference between levels at 35 and 40 wk of gestation (Table I ). The concentration of DBP in maternal serum was thus more than twice as high as DBP in cord serum (Tables I and II) . In women taking estro-progestogens, the DBP concentration was increased to a degree between the normal and pregnant levels (Table I) . No seasonal variation of DBP was observed (Fig. 1) .
25-Hydroxyvitamin D3. The concentration of 25-OHD3 in the serum of adults was not influenced by variations of serum DBP occurring during pregnancy or during intake of estro-progestogens (Table I) . Indeed, no correlation was found between serum 25-OHD3 and DBP in each subgroup of patients studied. A marked seasonal variation in serum 25-OHD3 level was observed both in maternal and in cord serum (Fig. 1) . A highly significant correlation was found between the concentration of25-OHD3 in maternal and cord serum, irrespective of season of delivery or gestational age (Table II) . Compared with normal women, the free 25-OHD3 index was significantly decreased during pregnancy and in women taking oral contraceptives, whereas the decrease in cord serum was less pronounced (Table I ). The total concentration of25-OHD3 was significantly higher in maternal serum than in cord serum, but the inverse situation was found for free 25-OHD3 (Table II) .
1,25-Dihydroxyvitamin D3. A significant positive correlation was found between the serum concentration of 1,25-(OH)2D3 and DBP in normal nonpregnant subjects with or without intake of estro-progestogens (Fig. 2) . A similar positive correlation between both measurements was also found in most adult or neonatal subgroups (Table I ). The concentration of 1,25-(OH)2D3 in maternal serum at each moment of gestation measured was significantly higher than in normal serum, whereas an intermediate concentration was found in the serum of patients taking estro-progestogens (Table I ). The major increase was already present at 15 wk of gestation, and the later increase was small (Fig. 3) . In cord serum obtained at 35 wk of gestation, the 1,25-(OH)2D3 concentration was lower than in the serum of nonpregnant females, but at 40 wk there was no significant difference (Table I) . The cord serum concentration of 1,25-(OH)2D3 was thus markedly lower than in the paired maternal serum, but the feto-maternal ratio was lower at 35 than at 40 weeks of gestation (Table II) . No seasonal variation Y_~gnancy, except at 40 wk of gestation (Table I) . Similarly, (Fig. 4) . Fig. 3. 0 (Fig. 2) . This is also the case in cord serum and serum of pregnant females at most gestational ages tested (Table I) . A similar positive relationship between other hormones and their respective transport protein has been documented (17) (18) (19) (20) (21) .
In contrast, no correlation was found between the concentration of 25-OHD3 and DBP, either in normal subjects, pregnant females, or women taking oral contraceptives (Table I) , confirming previous reports (3, 9, 12, 21) . The positive correlation between 1,25-(OH)2D3 and DBP indicates that the free steroid concentration is feedback regulated and thus physiologically important.
The concentrations of total 1,25-(OH)2D2 and DBP increase during the intake of estro-progestogens (9, 12) or estrogens alone (22) , whereas the 25-OHD3 level remains unchanged (Table I ). The free 25-OHD3 concentration therefore decreases, whereas the free 1,25-(OH)2D3 level remains unchanged (Table I ). Since it is well documented that the intestinal calcium absorption (25) (26) (27) (28) does not change during the intake of estrogens, even when given in huge amounts to produce pseudopregnancy (29) , and since bone resorption even seems to decrease (30) (31) , we assume that the free rather than the total concentration of 1,25-(OH)2D3 corresponds to its physiological effects on target cells. Indeed, in other situations with comparable increased concentrations of 1,25-(OH)2D3 not associated with increases in DBP (9, 13) , an important hyperabsorption of calcium is found (32) (33) (34) (35) . Administration of estrogens to osteoporotic women also increased the serum concentration of 1,25-(OH)2D3. Their free 1,25-(OH)2D3 concentration and their intestinal calcium absorption, however, both remained unchanged, indicating that the biological response of the target organ corresponds to the free rather than the total hormone concentration (36) . If the increase in serum 1,25-(OH)2D3 is only secondary to the increase in serum DBP, it becomes clear why the stimulatory effect of estrogens on 1,25-(OH)2D3 production in vivo (37, 38) cannot be observed in cultures of isolated kidney cells (39, 40) .
The serum concentration of 25-OHD3 in pregnant females does not differ from normal subjects (Table I) , whereas their serum DBP increases. This results in a decreased concentration of free 25-OHD3. The concentration of 1,25-(OH)2D3 increases during pregnancy (Fig. 3) , confirming previous data (4) (5) (6) (7) (8) month of pregnancy, however, a real increase in free 1,25-(OH)2D3 occurs, and this coincides with the period of large calcium transfer from the mother to the fetus (41) . Other data also favor this hypothesis, as the decrease in serum ionized calcium (42) and the increase in serum parathyroid hormone (43, 44) is also limited to the last period of pregnancy. Only scarce data on calcium absorption in human pregnancy are available. Using a single stable calcium isotope technique, an increased intestinal calcium absorption was already observed in early pregnancy (29) , when the free 1,25-(OH)D3 level is still normal. If these data were confirmed, an alternative explanation could be found in an altered sensitivity of the target organs, as is known for other hormones and even for 1,25-(OH)2D3 receptors (45) . Another study could not reveal, however, an increased calcium absorption in the first trimester of pregnancy (46) .
The concentration oftotal 1,25(OH)2D3 in cord serum is lower than in maternal serum, as has also been observed by Steichen et al. (7) . At 35 wk of gestation, the total and free 1,25(OH)2D3 concentrations in cord serum are not different from nonpregnant values. Between 35 and 40 wk of gestation, however, a significant increase in total and free 1,25(OH)2D3 occurs in parallel to their increase in maternal serum. A relatively high free or effective concentration of 1,25-(OH)2D3 is thus present in the phase of greatest fetal bone formation. This is in contrast with the recent interpretation that the low (total) fetal 1,25-(OH)2D3 levels reflect a lack of need for fetal intestinal calcium absorption (7) . The fetus, however, can absorb ingested amniotic fluid, and the normal (47) and even the prematurely born infant can absorb dietary calcium rather efficiently (48) . Moreover, Care et al. (49) recently demonstrated that fetal 1,25-(OH)2D3 is necessary to promote the maternal-to-fetal calcium flux across the placenta.
A positive correlation was found between the maternal and cord serum concentrations of either total or free 25-OHD3 (Fig. 2) . This confirms numerous previous reports (3, (50) (51) (52) (53) and is in agreement with a placental transfer of 25-OHD3 (54) . A positive correlation was also found between the maternal and cord serum concentrations of either total or free 1,25-(OH)2D3 both in premature and mature deliveries (Fig.  4) . Since DBP does not cross the placenta (55) , and free hormones in general are believed to be more important for the placental transfer than the total hormone concentration (56), we must suspect either an active placental transfer to the fetus or an additional synthesis of these vitamin D metabolites in the fetal compartment. Several data, indeed, demonstrate a fetal or placental synthesis of 1,25-(OH)2D3 (57) (58) (59) (60) . In a recent study, Steichen et al. (7) could not document a positive correlation between maternal and cord serum concentrations of 1,25-(OH)2D3. A model of separate maternal and fetal compartments of 1,25-(OH)2D3 was therefore suggested. They used venous cord blood instead of mixed cord blood as in the current study (7) , but this cannot be the reason for the discrepancy, because we could not detect any arteriovenous difference in either DBP or 1,25-(OH)2D3. Moreover, they did not find a positive correlation between the maternal and cord serum concentrations of 25-OHD3 either, contrary to many previous studies (3, (50) (51) (52) (53) . The placenta is generally considered permeable to the transfer of steroid hormones, because they are lipophilic substances of small size (56, 61) . A placental transfer of 1,25-(OH)2D3 has been demonstrated in the cow and sheep (49, 62) and to a lesser extent also in the rhesus monkey (63) , whereas conflicting results were obtained in rats (59, 64, 65) . Since the placental transfer of steroids probably depends more on their free than on their total concentrations (56) , a marked species difference can occur from variation in DBP gradients between both compartments (3, 66) . Until studies in man are available, our data can be interpreted either as an argument for direct placental transfer of 1,25-(OH)2D3 or for a regulation of the production of this hormone by one or more factors common to both compartments. Kinetic studies will be needed to solve the complex origin of 1,25-(OH)2D3 in the feto-matemal compartments.
The variation of 25-OHD3 observed at the end of pregnancy probably represents differences in nutritional intake or skin-production ofvitamin D. The wide variation in total or free 1,25-(OH)2D3, however, (Fig.  4) warrants further study regarding its cause as well as its consequences for both the mothers and the neonates.
